Stay updated with breaking news from Device Designation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Altoida, Inc. an artificial intelligence (AI) company pioneering next-generation neurological disease diagnostics and brain health solutions,...
Dexcom CGM to be evaluated for performance in the hospital and for the potential of more effective glycemic management and improved patient outcomes in the hospital settingBreakthrough Device Designation from the FDA is a critical milestone for in-patient Dexcom CGM useThis designation provides a more efficient and...
Cognito Therapeutics, a late-stage company pioneering non-invasive optogenetics-based therapies for neurodegenerative diseases, announced today it will present a virtual symposium featuring a panel
HEIDELBERG, GERMANY / ACCESSWIRE / February 22, 2022 / Heidelberg-based Precisis GmbH has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its EASEE brain
Investegate announcements from PRECISIS GmbH, Minimally Invasive Epilepsy Treatment EASEE Receives FDA Breakthrough Device Designation